These results provide strong evidence of biological activity of the high dose across multiple symptom areas, indicating the potential for disease modification rather than simply addressing isolated symptoms.
This will be the game changer modifying the long-term course of Retts will be a fantastic outcome, Autism next then concussion should be a high priority rather than TBI
GLTAH
- Forums
- ASX - By Stock
- Ann: Trofinetide significant clinical benefit in Rett syndrome
These results provide strong evidence of biological activity of...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8 | $18.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 3429 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 18.000 |
2 | 582 | 17.950 |
2 | 650 | 17.500 |
1 | 100 | 17.150 |
2 | 3116 | 17.100 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 3429 | 4 |
15.400 | 15 | 1 |
15.500 | 2500 | 1 |
15.800 | 1425 | 1 |
16.000 | 7061 | 2 |
Last trade - 16.16pm 08/08/2024 (20 minute delay) ? |
Featured News
NEWS
Is oil undervalued?
NEU (ASX) Chart |
Day chart unavailable